Skip to main content

Table 2 Characteristics of patients demonstrating LGE

From: Cardiac MRI utilizing late gadolinium enhancement (LGE) and T1 mapping in the detection of radiation induced heart disease

Patient number

Age

Time from EOT to CMR (mos)

Cancer site

LGE volume (cc)

Dmean EQD2 (Gy) to LGE

Dmean EQD2 (Gy) to heart

Dmax EQD2 (Gy) to LGE

Dmax EQD2 (Gy) to heart

D95 EQD2 (Gy) to LGE

1

87

28.3

lung

2.4

6.7

4.5

28.2

41.3

0.7

2

50

7.7

lung

0.2

16.5

4.7

25.5

48.8

0.9

3

67

22.1

lung

5.5

12.0

6.8

43.1

108

1.3

4

67

14.2

breast

1.0

12.4

1.8

16.1

40.8

8.7

5

65

2.2

breast

6.1

1.7

2.3

3.7

51.3

0.9

6

60

11.9

lung

2.2

0.4

4.1

0.5

66.6

0.3

7

71

26.5

esophagus

2.1

6.1

8.8

16.6

51.9

2.2

8

56

2.2

lung

0.5

10.9

21.8

13.2

69.9

9.1

9

74

6.0

lung

0.7

0.6

6.2

0.7

68.8

0.5

Average (Range)

66 (50–87)

13.4 (2.2–28.3)

–

2.3 (0.2–6.1)

7.5 (0.4–16.5)

6.8 (1.8–21.8)

16.4 (0.5–43.1)

60.8 (40.8–108.0)

2.7 (0.3–9.1)

  1. * Cc cubic centimeters, CMR cardiac magnetic resonance imaging, Dmax maximum dose, Dmean mean dose, D95 minimum dose to 95% of the LGE volume, EOT end of treatment date, EQD2 equivalent dose in 2Gy fractions, Gy Gray, LGE late gadolinium enhancement, mos months